Metabolic syndrome (MetS) belongs to the serious health complications expanding in cardiovascular diseases, obesity, insulin resistance, and hyperglycemia. In this study, hypertriacylglycerolemic rats fed a high-fat-fructose diet (HFFD) were used as an experimental model of MetS to explore the effect of tested compounds. Effects of a new prospective pyridoindole derivative coded SMe1EC2 and the natural polyphenol rutin were tested. Endothelial nitric oxide synthase (NOS3) and nuclear factor kappa B (NF-?B) expression were assessed in the left ventricle immunohistochemically and left ventricle activity was monitored in isolated perfused rat hearts. NOS3 activity in the left ventricle decreased markedly as a result of a HFFD. NOS3 expression was upregulated by both substances. NF-?B expression was increased in the MetS group in comparison to control rats and the expression further increased in the SMe1EC2 treatment. This compound significantly improved the coronary flow in comparison to the control group during reperfusion of the heart followed after ischemia. Further, it tended to increase left ventricular systolic pressure, heart product, rate of maximal contraction and relaxation, and coronary flow during baseline assessment. Moreover, the compound SMe1EC2 decreased the sensitivity of hearts to electrically induced ventricular fibrillation. Contrary to this rutin decreased coronary flow in reperfusion. Present results suggest that despite upregulation of NOS3 by both substances tested, pyridoindole SMe1EC2 rather than rutin could be suitable in treatment strategies of cardiovascular disorders in MetS-like conditions.

Department of Pharmacology and Toxicology Faculty of Pharmacy Comenius University Bratislava Slovak Republic

Zobrazit více v PubMed

BEG AA, BALTIMORE D. An essential role of NF-κB in preventing TNF-alpha-induced cell death. Science. 1996;274:782–784. doi: 10.1126/science.274.5288.782. PubMed DOI

BEZEK S, BRNOLIAKOVA Z, SOTNIKOVA R, KNEZL V, PAULOVICOVA E, NAVAROVA J, BAUER V. Monotherapy of experimental metabolic syndrome: I. Efficacy and safety. Interdisc Toxicol. 2017;10:81–85. doi: 10.1515/intox-2017-0013. PubMed DOI PMC

BHANDARY B, PIAO CS, KIM DS, LEE GH, CHAE SW, KIM HR, CHAE HJ. The protective effect of rutin against ischemia/reperfusion-associated hemodynamic alteration through antioxidant activity. Arch Pharm Res. 2012;35:1091–1097. doi: 10.1007/s12272-012-0617-6. PubMed DOI

BIERHAUS A, SCHIEKOFER S, SCHWANINGER M, ANDRASSY M, HUMPERT PM, CHEN J, HONG M, LUTHER T, HENLE T, KLOTING I, MORCOS M, HOFMANN M, TRITSCHLER H, WEIGLE B, KASPER M, SMITH M, PERRY G, SCHMIDT AM, STERN DM, HARING HU, SCHLEICHER E, NAWROTH PP. Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB. Diabetes. 2001;50:2792–2808. doi: 10.2337/diabetes.50.12.2792. PubMed DOI

BOCCELLINO M, D’ANGELO S. Anti-obesity effects of polyphenol intake: Current status and future possibilities. Int J Mol Sci. 2020;21:5642. doi: 10.3390/ijms21165642. PubMed DOI PMC

BOEHM, NOVOYATLEVA T, KOJONAZAROV B, VEIT F, WEISSMANN N, GHOFRANI HA, SEEGER W, SCHERMULY RT. Nitric oxide synthase 2 induction promotes right ventricular fibrosis. Am J Respir Cell Mol Biol. 2019;60:346–356. doi: 10.1165/rcmb.2018-0069OC. PubMed DOI

BOUDAKA A, AL-SULEIMANI M, AL-LAWATI I, BAOMAR H, AL-SIYABI S, ZADJALI F. Downregulation of endothelial transient receptor potential vanilloid type 4 channel underlines impaired endothelial nitric oxide mediated relaxation in the mesenteric arteries of hypertensive rats. Physiol Res. 2019;68:219–231. doi: 10.33549/physiolres.933952. PubMed DOI

BOURCIER T, SUKHOVA G, LIBBY P. The nuclear factor kappa-B signaling pathway participates in dysregulation of vascular smooth muscle cells in vitro and in human atherosclerosis. J Biol Chem. 1997;272:15817–15824. doi: 10.1074/jbc.272.25.15817. PubMed DOI

BRUTSAERT DL. Cardiac endothelial-myocardial signaling: Its tole in cardiac growth, contractile performance, and rhytmicity. Phys Rev. 2003;83:59–115. doi: 10.1152/physrev.00017.2002. PubMed DOI

CIZKOVA K, FOLTYNKOVA T, GACHECHILADZE M, TAUBER Z. Comparative analysis of immunohistochemical staining intensity determined by light microscopy, ImageJ and QuPath in placental Hofbauer cells. Acta Histochem Cytochem. 2021;54:21–29. doi: 10.1267/ahc.20-00032. PubMed DOI PMC

DEANFIELD JE, HALCOX JP, RABELINK TJ. Endothelial function and dysfunction: testing and clinical relevance. Circulation. 2007;115:1285–1295. doi: 10.1161/CIRCULATIONAHA.106.652859. PubMed DOI

FERENCZYOVA K, KALOCAYOVA B, KINDERNAY L, JELEMENSKY M, BALIS P, BERENYIOVA A, ZEMANCIKOVA A, FARKASOVA V, SYKORA M, TOTHOVA L, JASENOVEC T, RADOSINSKA J, TOROK J, CACANYIOVA S, BARANCIK M, BARTEKOVA M. Quercetin exerts age-dependent beneficial effects on blood pressure and vascular function, but is inefficient in preventing myocardial ischemia-reperfusion injury in Zucker Diabetic Fatty rats. Molecules. 2020;25:187. doi: 10.3390/molecules25010187. PubMed DOI PMC

FRIESENECKER B, TSAI AG, ALLEGRA C, INTAGLIETA M. Oral administration of purified micronized flavonoid fraction suppresses leukocyte adhesion in ischemia-reperfusion injury: in vivo observations in the hamster skin fold. Int J Microcirc Clin Exp. 1994;14:50–55. doi: 10.1159/000178206. PubMed DOI

GASPAROVA Z, JANEGA P, WEISMANN P, EL FALOUGY H, TYUKOS KAPRINAY B, LIPTAK B, MICHALIKOVA D, SOTNIKOVA R. Effect of metabolic syndrome on neural plasticity and morphology of the hippocampus: correlations of neurological deficits with physiological status of the rat. Gen Physiol Biophys. 2018;37:619–632. doi: 10.4149/gpb_2018016. PubMed DOI

GRUNDY SM. Metabolic syndrome: a multiplex cardiovascular risk factor. J Clin Endocrinol Metab. 2007;92:399–404. doi: 10.1210/jc.2006-0513. PubMed DOI

GUIMARAES JFC, MUZIO BP, ROSA CM, NASCIMENTO AF, SUGIZAKI MM, FERNANDES AAH, CICOGNA AC, PADOVANI CR, OKOSHI MP, OKOSHI K. Rutin administration attenuates myocardial dysfunction in diabetic rats. Cardiovasc Diabetol. 2015;14:90. doi: 10.1186/s12933-015-0255-7. PubMed DOI PMC

HASEGAWA Y, SAITO T, OGIHARA T, ISHIGAKI Y, YAMADA T, IMAI J, UNO K, GAO J, KANEKO K, SHIMOSAWA T, ASANO T, FUJITA T, OKA Y, KATAGIRI H. Blockade of the nuclear factor-kappaB pathway in the endothelium prevents insulin resistance and prolongs life spans. Circulation. 2012;125:1122–1133. doi: 10.1161/CIRCULATIONAHA.111.054346. PubMed DOI

HAUSENLOY DJ, YELLON DM. The therapeutic potential of ischemic conditioning: An update. Nat Rev Cardiol. 2011;8:619–629. doi: 10.1038/nrcardio.2011.85. PubMed DOI

HUANG PL. eNOS, metabolic syndrome and cardiovascular disease. Trends Endocrinol Metab. 2009;20:295–302. doi: 10.1016/j.tem.2009.03.005. PubMed DOI PMC

HUANG PL, HUANG Z, MASHIMO H, BLOCH KD, MOSKOWITZ MA, BEVAN JA, FISHMAN MC. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature. 1995;377:239–242. doi: 10.1038/377239a0. PubMed DOI

ITANI SI, RUDERMAN NB, SCHMIEDER F, BODEN G. Lipid induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha. Diabetes. 2002;51:2005–2011. doi: 10.2337/diabetes.51.7.2005. PubMed DOI

JURANEK I, HORAKOVA L, RACKOVA L, STEFEK M. Antioxidants in treating pathologies involving oxidative damage: an update on medicinal chemistry and biological activity of stobadine and related pyridoindoles. Review. Curr Med Chem. 2010;17:552–570. doi: 10.2174/092986710790416317. PubMed DOI

KAPRINAY B, GASPAROVA Z, LIPTAK B, FRIMMEL K, SOTNIKOVA R. Endothelial dysfunction in experimental models of metabolic syndrome - effect of fructose. Eur Pharm J. 2017;64:4–6. doi: 10.1515/afpuc-2017-0014. DOI

KAPRINAY B, LIPTAK B, SLOVAK L, SVIK K, KNEZL V, SOTNIKOVA R, GASPAROVA Z. Hypertriglyceridemic rats fed high fat diet as a model of metabolic syndrome. Physiol Res. 2016;65(Suppl 4):S515–S518. doi: 10.33549/physiolres.933524. PubMed DOI

KERRY NL, ABBEY M. Red wine and fractionated phenolic compounds prepared from red wine inhibit low density lipoprotein oxidation in vitro. Atherosclerosis. 1997;135:93–102. doi: 10.1016/S0021-9150(97)00156-1. PubMed DOI

KMECOVA J, KLIMAS J. Heart rate correction of the QT duration in rats. Eur J Pharmacol. 2010;641:187–192. doi: 10.1016/j.ejphar.2010.05.038. PubMed DOI

KNEZL V, SOTNIKOVA R, BRNOLIAKOVA Z, STANKOVICOVA T, BAUER V, BEZEK S. Monotherapy of experimental metabolic syndrome: II. Study of cardiovascular effects. Interdisc Toxicol. 2017;10:86–92. doi: 10.1515/intox-2017-0014. PubMed DOI PMC

KRALOVA E, MOKRAN T, MURIN J, STANKOVICOVA T. Electrocardiography in two models of isoproterenol-induced left ventricular remodeling. Physiol Res. 2008;57(Suppl 2):S83–89. doi: 10.33549/physiolres.931556. PubMed DOI

KRISHNA KM, ANNAPURNA A, GOPAL GS, CHALAM CRV, MADAN K, KUMAR VK, PRAKASH GJ. Partial reversal by rutin and quercetin of impaired cardiac function in streptozotocin-induced diabetic rats. Canad J Physiol Pharmacol. 2005;83:343–355. doi: 10.1139/y05-009. PubMed DOI

LIPTAK B, KNEZL V, GASPAROVA Z. Anti-arrhythmic and cardio-protective effects of atorvastatin and a potent pyridoindole derivative on isolated hearts from rats with metabolic syndrome. Bratisl Med J. 2019;120:200–206. doi: 10.4149/BLL_2019_034. PubMed DOI

LIU X, LIN R, ZHAO B, GUAN R, LI T, JIN R. Correlation between oxidative stress and the NF κB signaling pathway in the pulmonary tissues of obese asthmatic mice. Mol Med Rep. 2016;13:1127–1134. doi: 10.3892/mmr.2015.4663. PubMed DOI PMC

LV L, YAO Y, ZHAO G, ZHU G. Rutin inhibits coronary heart disease through ERK1/2 and Akt signaling in a porcine model. Exp Ther Med. 2018;15:506–512. doi: 10.3892/etm.2017.5365. PubMed DOI PMC

MICHALIKOVA D, TYUKOS KAPRINAY B, LIPTAK B, SVIK K, SLOVAK L, SOTNIKOVA R, KNEZL V, GASPAROVA Z. Natural substance rutin versus standard drug atorvastatin in a treatment of metabolic syndrome-like condition. Saudi Pharm J. 2019;27:1196–1202. doi: 10.1016/j.jsps.2019.10.002. PubMed DOI PMC

MONORI-KISS A, KISS F, RESTIFO JM, MONOS E, NADASY GL. Chronic administration of quercetin induces biomechanical and pharmacological remodeling in the rat coronary arteries. Physiol Res. 2017;66:591–599. doi: 10.33549/physiolres.933384. PubMed DOI

NACHIMUTHU S, ASSAR MD, SCHUSSLER JM. Drug-induced QT interval prolongation: mechanisms and clinical management. Ther Adv Drug Res. 2012;3:241–253. doi: 10.1177/2042098612454283. PubMed DOI PMC

NISHIKAWA T, EDELSTEIN D, DU XL, YAMAGISHI S, MATSUMURA T, KANEDA Y, YOREK MA, BEEBE D, OATES PJ, HAMMES HP, GIARDINO I, BROWNLEE M. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature. 2000;404:787–789. doi: 10.1038/35008121. PubMed DOI

ONAI Y, SUZUKI J, MAEJIMA Y, HARAGUCHI G, MUTO S, ITAI A, ISOBE M. Inhibition of NF-kappaB improves left ventricular remodeling and cardiac dysfunction after myocardial infarction. Am J Physiol Heart Circ Physiol. 2007;292:H530–H538. doi: 10.1152/ajpheart.00549.2006. PubMed DOI

PARSANATHAN R, JAIN SK. Novel invasive and noninvasive cardiac-specific biomarkers in obesity and cardiovascular diseases. Metab Syndr Relat Disord. 2020;18:10–30. doi: 10.1089/met.2019.0073. PubMed DOI PMC

PENG L, YHANG Q, ZHANG Y, YAO Z, SONG P, WEI L, ZHAO G, YAN Z. Effect of tartary buckwheat, rutin, and quercetin on lipid metabolism in rats during high dietary fat intake. Food Sci Nutr. 2020;8:199–213. doi: 10.1002/fsn3.1291. PubMed DOI PMC

PRINCE P, KAMALAKKANNAN N. Rutin improves glucose homeostasis in streptozotocin diabetic tissues by altering glycolytic and gluconeogenic enzymes. J Biochem Mol Toxicol. 2006;20:96–102. doi: 10.1002/jbt.20117. PubMed DOI

REAVEN GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988;37:1595–1607. doi: 10.2337/diabetes.37.12.1595. PubMed DOI

ROBERTS CK, SINDHU KK. Oxidative stress and metabolic syndrome. Life Sci. 2009;84:705–712. doi: 10.1016/j.lfs.2009.02.026. PubMed DOI

SCHINDELIN J, ARGANDA-CARRERAS I, FRISE E, KAYNIG V, LONGAIR M, PIETZSCH T, PRIBISCH S, RUEDEN C, SAALFELD S, SCHMID B, TINEVEZ J-Y, WHITE DJ, HARTENSTEIN V, ELICEIRI K, TOMANCAK P, CARDONA A. Fiji: An open-source platform for biological-image analysis. Nature Methods. 2012;9:676–682. doi: 10.1038/nmeth.2019. PubMed DOI PMC

SHOSKES DA. Effect of bioflavonoids quercetin and curcumin on ischemic renal injury: a new class of renoprotective agents. Transplantation. 1998;66:147–152. doi: 10.1097/00007890-199807270-00001. PubMed DOI

SOTNIKOVA R, NEDELCEVOVA J, NAVAROVA J, NOSALOVA V, DRABIKOVA K, SZOCS K, KRENEK P, KYSELOVA Z, BEZEK S, KNEZL V, DRIMAL J, BROSKOVA Z, KRISTOVA V, OKRUHLICOVA L, BERNATOVA I, BAUER V. Protection of the vascular endothelium in experimental situations. Interdiscip Toxicol. 2011;4:20–26. doi: 10.2478/v10102-011-0005-y. PubMed DOI PMC

STOLC S, SNIRC V, MAJEKOVA M, GASPAROVA Z, GAJDOSIKOVA A, STVRTINA S. Development of the new group of indole-derived neuroprotective drugs affecting oxidative stress. Cell Mol Neurobiol. 2006;26:1495–1504. doi: 10.1007/s10571-006-9037-9. PubMed DOI

UGUSMAN A, ZAKARIA Z, CHUA KH, NORDIN NA, MAHDY ZA. Role of rutin on nitric oxide synthesis in human umbilical vein endothelial cells. Sci World J. 2014;2014:169370. doi: 10.1155/2014/169370. PubMed DOI PMC

Van Der HEIDEN K, CUHLMANN S, LUONG LA, ZAKKAR M, EVANS PC. Role of nuclear factor kappaB in cardiovascular health and disease. Clin Sci (Lond) 2010;118:593–605. doi: 10.1042/CS20090557. PubMed DOI

VENURAJU SM, YERRAMASU A, CORDER R, LAHIRI A. Osteoprotegerin as a predictor of coronary artery disease and cardiovascular mortality and morbidity. J Am Coll Cardiol. 2010;55:2049–2061. doi: 10.1016/j.jacc.2010.03.013. PubMed DOI

WANG W, WU QH, SUI Y, WANG Y, QIU X. Rutin protects endothelial dysfunction by disturbing Nox4 and ROS-sensitive NLRP3 inflammasome. Biomed Pharmacother. 2017;86:32–40. doi: 10.1016/j.biopha.2016.11.134. PubMed DOI

YOO SY, AHN H, PARK YK. High dietary fructose intake on cardiovascular disease related parameters in growing rats. Nutrients. 2017;9:11. doi: 10.3390/nu9010011. PubMed DOI PMC

ZICHA J, PECHANOVA O, CACANYOVA S, CEBOVA M, KRISTEK F, TOROK J, SIMKO F, DOBESOVA Z, KUNES J. Hereditary hypertriglyceridemic rat a suitable model of cardiovascular disease and metabolic syndrome? Physiol Res. 2006;55:49–63. PubMed

Metabolic Syndrome in Hypertriglyceridemic Rats: Effects of Antioxidants